We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRMD icon
3476
CorMedix
CRMD
$592M
$21K ﹤0.01%
3,914
+919
+31% +$4.21K
CSR
3477
Centerspace
CSR
$938M
$21K ﹤0.01%
220
-271
-55% -$26.3K
CVAC
3478
DELISTED
CureVac
CVAC
$21K ﹤0.01%
1,116
-2,415
-68% -$48.2K
DCGO icon
3479
DocGo
DCGO
$65.9M
$21K ﹤0.01%
+2,320
New +$17.5K
EWTX icon
3480
Edgewise Therapeutics
EWTX
$4.8B
$21K ﹤0.01%
2,142
+861
+67% +$11.1K
EWY icon
3481
iShares MSCI South Korea ETF
EWY
$27.8B
$21K ﹤0.01%
287
-897
-76% -$65.1K
FMAT icon
3482
Fidelity MSCI Materials Index ETF
FMAT
$614M
$21K ﹤0.01%
426
-2,875
-87% -$137K
FTDR icon
3483
Frontdoor
FTDR
$5.96B
$21K ﹤0.01%
699
-5,914
-89% -$197K
FTSM icon
3484
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
$21K ﹤0.01%
+345
New +$20.6K
JACK icon
3485
Jack in the Box
JACK
$325M
$21K ﹤0.01%
231
-3,824
-94% -$338K
KRO icon
3486
KRONOS Worldwide
KRO
$975M
$21K ﹤0.01%
1,326
+516
+64% +$7.67K
KROS icon
3487
Keros Therapeutics
KROS
$200M
$21K ﹤0.01%
377
-1,300
-78% -$66.7K
LU icon
3488
Lufax Holding
LU
$1.3B
$21K ﹤0.01%
921
-16,403
-95% -$361K
NRDY icon
3489
Nerdy
NRDY
$90.4M
$21K ﹤0.01%
4,115
+1,290
+46% +$5.75K
HTT
3490
High Templar Tech Ltd
HTT
$393M
$21K ﹤0.01%
+17,682
New +$16.9K
QNCX icon
3491
Quince Therapeutics
QNCX
$34.6M
$21K ﹤0.01%
17
-14
-45% -$19.1K
RILY icon
3492
BRC Group Holdings
RILY
$299M
$21K ﹤0.01%
294
-1,306
-82% -$88.4K
RXRX icon
3493
Recursion Pharmaceuticals
RXRX
$1.69B
$21K ﹤0.01%
2,938
-1,171
-28% -$12.4K
FIRY
3494
Firy Inc
FIRY
$148M
$21K ﹤0.01%
352
-456
-56% -$37.2K
SNCR
3495
DELISTED
Synchronoss Technologies
SNCR
$21K ﹤0.01%
1,327
+1,032
+350% +$17.6K
TCX icon
3496
Tucows
TCX
$126M
$21K ﹤0.01%
313
+116
+59% +$8.57K
TISI icon
3497
Team
TISI
$101M
$21K ﹤0.01%
925
-27
-3% -$281
TRVI icon
3498
Trevi Therapeutics
TRVI
$2.63B
$21K ﹤0.01%
9,477
+1,160
+14% +$1.2K
TSAT icon
3499
Telesat
TSAT
$771M
$21K ﹤0.01%
1,286
-249
-16% -$5.55K
UCTT
3500
Ultra Clean Holdings
UCTT
$3.85B
$21K ﹤0.01%
498
-113
-18% -$5.41K
138 139
140
141 142

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.